Endostar plus gemcitabine/cisplatin (GP) with maintenance endostar as first-line therapy for advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study

被引:0
|
作者
Lu, You
Huang, Meijuan
Fan, Qingxia
Wu, Qi
Wang, Jin
Li, Lu
Zhang, Xi
Guo, Chengye
Li, Wenhui
Peng, Feng
Ouyang, Xuenong
Yu, Ding
Cai, Xiaohong
Xu, Yong
Hou, Mei
Luo, Rongcheng
Zhang, Tao
机构
[1] Sichuan Univ, Dept Thorac Oncol, State Key Lab Biotherapy, Huaxi Hosp, Chengdu 610064, Peoples R China
[2] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp, Chengdu 610064, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[4] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China
[5] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp,Med Sch, Chengdu 610064, Peoples R China
[6] Third Peoples Hosp Chengdu, Chengdu, Peoples R China
[7] Qingdao Municipal Hosp, Qingdao, Peoples R China
[8] Yunnan Canc Hosp, Kunming, Peoples R China
[9] Nanjing Mil Command, Fuzhou Gen Hosp, Fuzhou, Peoples R China
[10] Hubei Canc Hosp, Wuhan, Peoples R China
[11] Sichuan Canc Hosp, Chengdu, Peoples R China
[12] Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[13] Chengdu Mil Gen Hosp, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18033
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A Study of Endostar Combined with Gemcitabine in the First-Line Treatment of the Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Chen, Qun
    She, Qin
    Xie, Qiang
    Xiao, Song
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S889 - S890
  • [2] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [3] A phase II trial of adding cetuximab to cisplatin and gemcitabine as first-line therapy in advanced non-small cell lung cancer (NSCLC)
    Barata, F.
    Parente, B.
    Teixeira, E.
    Costa, A.
    Fernandes, A.
    Pimentel, F. L.
    Carvalho, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [5] Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: Preliminary results
    Belli, L
    LeChevalier, T
    Gottfried, M
    Adams, D
    Ruffle, P
    LeCesne, A
    Tete, L
    PellaeCosset, B
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (06) : 29 - 33
  • [6] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    [J]. CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
  • [7] THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Wielage, R. C.
    Muehlenbein, C. E.
    Liepa, A. M.
    Babineaux, S. M.
    Klein, R. W.
    Schwartzberg, L. S.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A39 - A39
  • [8] Phase II study of gemcitabine plus oxaliplatin as first-line treatment in elderly or unfit patients with advanced non-small cell lung cancer (NSCLC).: Across
    Domènech, M
    Losa, F
    Blanco, R
    Nogué, M
    Montesinos, J
    Mesía, C
    Gallardo, E
    de Olaguer, JP
    [J]. LUNG CANCER, 2005, 49 : S242 - S242
  • [9] Gemcitabine (G) plus cisplatin (C) in advanced non-small cell lung cancer (NSCLC): Final phase II results.
    Casal, J
    Huidobro, G
    Grande, C
    Caeiro, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [10] Economic analysis of TORCH: Erlotinib versus cisplatin and gemcitabine as first-line therapy for advanced non-small cell lung cancer (NSCLC).
    Chung, Carmen
    Isaranuwatchai, Wanrudee
    Di Maio, Massimo
    Jiang, Haiyan
    Lau, Anthea
    Hoch, Jeffrey S.
    Feld, Ronald
    Tsao, Ming Sound
    Gridelli, Cesare
    Ciardiello, Fortunato
    Butts, Charles Andrew
    Gallo, Ciro
    Perrone, Francesco
    Leighl, Natasha B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)